e-ISSN: Pending
Negative / Null Result ReportOpen accessDiseases of the circulatory (Cardiovascular) system

Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation

Takumi Osawa; Hitoshi Mori; Akane Kawai; Daisuke Kawano; Kenta Tsutsui; Yoshifumi Ikeda; Mitsuki Yamaga; Atsushi Sato · 2022 · Journal of Arrhythmia

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Abstract Background Uninterrupted dabigatran during atrial fibrillation (AF) ablation is now established as the standard therapy. However, there are few reports on the effects of uninterrupted dabigatran on the intensity of anticoagulation during AF ablation. Methods We retrospectively analyzed 247 consecutive patients who underwent AF ablation in our hospital from January 2017 to December 2018. Patients who took warfarin or uninterrupted direct oral anticoagulants (DOACs) except for dabigatran were excluded. 89 patients underwent ablation with uninterrupted dabigatran (uninterrupted group, ma

Abstract by Takumi Osawa; Hitoshi Mori; Akane Kawai; Daisuke Kawano; Kenta Tsutsui; Yoshifumi Ikeda; Mitsuki Yamaga; Atsushi Sato, Journal of Arrhythmia (2022) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1002/joa3.12655